
Pharmaceutical manufacturer and researcher specializing in cannabis-based plant therapeutics and USDA-compliant THC testing.
Biopharmaceutical Research Company develops active pharmaceutical ingredients for plant therapeutics, focusing on cannabis-based products. The company specializes in producing cannabis for researchers across the United States and conducting USDA-compliant THC testing of hemp. With full DEA compliance for botanically derived cannabinoids, BRC aims to address unmet medical needs using innovative cannabinoid therapeutics.
BRC has developed proprietary poly-cannabinoids in titratable formulations, demonstrating their commitment to advancing cannabinoid research. The company's mission centers on creating safe and effective cannabinoid-based treatments, positioning itself at the forefront of this emerging field in pharmaceutical development. BRC's work contributes to the growing body of knowledge surrounding the potential medical applications of cannabis-derived compounds.

Diverse Biotech

Skye Bioscience

Outlier Biopharma

Agronomed Pharmaceuticals
agronomed.com
THC Farmaceuticals
toke.city

Platinum Biosciences

FarmaceuticalRx

Applied Biosciences

Franklin Group

Natural State Medical Group

Emerald Health Pharmaceuticals

RS BioTherapeutics

Colorado Hemp Institute

CNBX Pharmaceuticals
cnbxpharma.com

Wellcana
Companies similar to Biopharmaceutical Research include Diverse Biotech, Skye Bioscience, Outlier Biopharma and Agronomed Pharmaceuticals.
Biopharmaceutical Research was founded in 2017.
Biopharmaceutical Research's headquarters is located in Castroville, CA, US.
Biopharmaceutical Research's most recent funding round was for $20M (USD) in October 2022.
As of Oct 4, 2022, Biopharmaceutical Research has raised a total of $20M (USD).
Biopharmaceutical Research has 22 employees as of Feb 5, 2024.